Entity Details

Primary name ALG2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9H553
EntryNameALG2_HUMAN
FullNameAlpha-1,3/1,6-mannosyltransferase ALG2
TaxID9606
Evidenceevidence at protein level
Length416
SequenceStatuscomplete
DateCreated2004-04-13
DateModified2021-06-02

Ontological Relatives

GenesALG2

GO terms

Show/Hide Table
GOName
GO:0000033 alpha-1,3-mannosyltransferase activity
GO:0004378 GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005789 endoplasmic reticulum membrane
GO:0005829 cytosol
GO:0006488 dolichol-linked oligosaccharide biosynthetic process
GO:0006490 oligosaccharide-lipid intermediate biosynthetic process
GO:0015629 actin cytoskeleton
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0033577 protein glycosylation in endoplasmic reticulum
GO:0046982 protein heterodimerization activity
GO:0047485 protein N-terminus binding
GO:0048306 calcium-dependent protein binding
GO:0048471 perinuclear region of cytoplasm
GO:0051592 response to calcium ion
GO:0102704 GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity

Subcellular Location

Show/Hide Table
Subcellular Location
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001296 Glycosyl transferase, family 1DomainDomain
IPR027054 Mannosyltransferase ALG2FamilyFamily
IPR028098 Glycosyltransferase subfamily 4-like, N-terminal domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607906 OMIMCongenital disorder of glycosylation 1I (CDG1I)A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. The disease is caused by variants affecting the gene represented in this entry.
616228 OMIMMyasthenic syndrome, congenital, 14 (CMS14)A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness. CMS14 is an autosomal recessive form characterized by onset of limb-girdle muscle weakness in early childhood. The disorder is slowly progressive, and some patients may become wheelchair-bound. The disease is caused by variants affecting the gene represented in this entry.